Immunogenicity and protective efficacy of an anti-Streptococcus pyogenes vaccine candidate in multiple animal species

M Sheel - 2010 - eprints.qut.edu.au
Streptococcus pyogenes, also known as Group A Streptococcus (GAS) has been associated
with a range of diseases from the mild pharyngitis and pyoderma to more severe invasive …

Group A streptococcal vaccines: paving a path for accelerated development

JB Dale, VA Fischetti, JR Carapetis, AC Steer, S Sow… - Vaccine, 2013 - Elsevier
Group A streptococci (GAS) are important causes of morbidity and mortality worldwide.
These organisms cause a wide spectrum of disease, ranging from uncomplicated sore throat …

Recent Scientific Advancements towards a Vaccine against Group A Streptococcus

J Fan, I Toth, RJ Stephenson - Vaccines, 2024 - mdpi.com
Group A Streptococcus (GAS), or Streptococcus pyogenes, is a gram-positive bacterium that
extensively colonises within the human host. GAS is responsible for causing a range of …

Correlates of Protection for M Protein‐Based Vaccines against Group A Streptococcus

SK Tsoi, PR Smeesters, HRC Frost… - Journal of …, 2015 - Wiley Online Library
Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from
pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and …

Progress in development of group A streptococcus vaccines

Y Song, X Zhang, C Lu, F Zhang… - Current pharmaceutical …, 2013 - ingentaconnect.com
Streptococcus pyogenes or Group A Streptococcus (GAS) is a major Gram-positive human
pathogen that causes diverse human diseases with a high morbidity and mortality …

Vaccine development for group a streptococcus infections and associated diseases

MR Batzloff, KS Sriprakash, MF Good - Current Drug Targets, 2004 - ingentaconnect.com
Group A streptococcus (GAS) is responsible for a number of diseases ranging from
uncomplicated pharyngitis through to life-treating invasive and post-infectious diseases such …

[HTML][HTML] Group A Streptococcus Infections: Their Mechanisms, Epidemiology, and Current Scope of Vaccines

V Iyer, V Sagar, D Toor, V Lyngdoh, G Nongrum… - Cureus, 2022 - ncbi.nlm.nih.gov
Group A streptococci (GAS) are gram-positive, cocci-shaped bacteria that cause a wide
variety of infections and are a cause of significant health burden, particularly in lower-and …

A multicomponent vaccine provides Immunity against local and systemic infections by group a Streptococcus across serotypes

S Bi, M Xu, Y Zhou, X Xing, A Shen, B Wang - MBio, 2019 - Am Soc Microbiol
Group A streptococcus (GAS) species are responsible for a broad spectrum of human
diseases, ranging from superficial to invasive infections, and are associated with …

Group A streptococcal vaccine candidates: potential for the development of a human vaccine

A Henningham, CM Gillen, MJ Walker - Host-pathogen interactions in …, 2012 - Springer
Currently there is no commercial Group A Streptococcus (GAS; S. pyogenes) vaccine
available. The development of safe GAS vaccines is challenging, researchers are …

Development of subunit vaccines for Group A Streptococcus

C Olive - Molecular Vaccines: From Prophylaxis to Therapy …, 2013 - Springer
There is currently no available vaccine to prevent infection with Streptococcus pyogenes
(also known as group A streptococcus, GAS), which can lead to the life-threatening diseases …